Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BACKGROUND: Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (PCNSL) is a rare disorder with an increasing incidence over the past decades. High-level evidence has been reported for the MATRix regimen (high-dose methotrexate (HD-MTX), high-dose AraC (HD-AraC), thiotepa and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wendler, Julia, Fox, Christopher P., Valk, Elke, Steinheber, Cora, Fricker, Heidi, Isbell, Lisa K., Neumaier, Simone, Okosun, Jessica, Scherer, Florian, Ihorst, Gabriele, Cwynarski, Kate, Schorb, Elisabeth, Illerhaus, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464101/
https://www.ncbi.nlm.nih.gov/pubmed/36088292
http://dx.doi.org/10.1186/s12885-022-09723-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464101/
https://www.ncbi.nlm.nih.gov/pubmed/36088292
http://dx.doi.org/10.1186/s12885-022-09723-w

Ejemplares similares